Phenotype‐driven molecular autopsy for sudden cardiac death

A phenotype‐driven approach to molecular autopsy based in a multidisciplinary team comprising clinical and laboratory genetics, forensic medicine and cardiology is described. Over a 13 year period, molecular autopsy was undertaken in 96 sudden cardiac death cases. A total of 46 cases aged 1–40 years had normal hearts and suspected arrhythmic death. Seven (15%) had likely pathogenic variants in ion channelopathy genes [ KCNQ1 (1), KCNH2 (4), SCN5A (1), RyR2 (1)]. Fifty cases aged between 2 and 67 had a cardiomyopathy. Twenty‐five had arrhythmogenic right ventricular cardiomyopathy ( ARVC ), 10 dilated cardiomyopathy ( DCM ) and 15 hypertrophic cardiomyopathy ( HCM ). Likely pathogenic variants were found in three ARVC cases (12%) in PKP2 , DSC2 or DSP , two DCM cases (20%) in MYH7 , and four HCM cases (27%) in MYBPC3 (3) or MYH7 (1). Uptake of cascade screening in relatives was higher when a molecular diagnosis was made at autopsy. In three families, variants previously published as pathogenic were detected, but clinical investigation revealed no abnormalities in carrier relatives. With a conservative approach to defining pathogenicity of sequence variants incorporating family phenotype information and population genomic data, a molecular diagnosis was made in 15% of sudden arrhythmic deaths and 18% of cardiomyopathy deaths.